Rambus (RMBS) Updates on Patent Appeal; Say Court Upholds Rejection of Claim 18, Prior PTO Decisions Unchanged
Tweet Send to a FriendGet Alerts RMBS Hot Sheet
Up)
Trade RMBS Now!
Rambus Inc. (Nasdaq: RMBS), announced that the United States Court of Appeals for the Federal Circuit (Federal Circuit) has issued its decision in Rambus's appeal of an ex parte reexamination of Rambus patent No. 6,034,918 (918).
Although the Federal Circuit has affirmed the United States Patent and Trademark Office’s (PTO) rejection of claim 18, the decision does not affect the PTO's previous confirmation of the two other claims challenged in the reexamination. These two claims were asserted by Rambus and in a jury trial before Judge Whyte in the Northern District of California found to be infringed by SK Hynix. Claim 18 was not asserted in that patent trial.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Although the Federal Circuit has affirmed the United States Patent and Trademark Office’s (PTO) rejection of claim 18, the decision does not affect the PTO's previous confirmation of the two other claims challenged in the reexamination. These two claims were asserted by Rambus and in a jury trial before Judge Whyte in the Northern District of California found to be infringed by SK Hynix. Claim 18 was not asserted in that patent trial.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Sprint (S), SoftBank Receive Final State Regulatory Approval in Proposed Deal
- Apricus Bio (APRI) Prices 6M Common Stock Offering
- Brocade (BRCD), A10 Settle Litigation; Brocade to Get $5M Cash, $70M Conv. Note
Create E-mail Alert Related Categories
Corporate News, Litigation
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
